The legacy of Viagra and the pharmaceutical industry presents a complex picture for potential investors. Initially, copyright's blockbuster drug altered the treatment of erectile dysfunction, generating substantial profits and defining the current pharmaceutical landscape. However, intellectual property expiration and the rise of generic versions h